Regent Pacific Group Limited
Research Regent Pacific Group Limited (0575.HK) on Bullrun: market cap HKD 252.42M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0575.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 252.42M
- Financial periodFY2025
- RevenueUSD 363.00K
- Revenue growth-49.5%
- Net income-USD 4.71M
- Free cash flow-USD 4.31M
Valuation Snapshot
latest market cap is HKD 252.42M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 363.00K | -USD 4.71M | -USD 4.31M | n/a | -0.02 | USD 135.00K | USD 3.94M | -USD 6.64M |
| FY2024 | USD 719.00K | -USD 4.48M | -USD 4.14M | -295.0% | -0.02 | USD 100.00K | USD 3.34M | -USD 5.90M |
| FY2023 | USD 291.00K | -USD 25.05M | -USD 3.81M | -836.1% | -0.11 | USD 2.10M | USD 1.20M | -USD 1.55M |
| FY2022 | USD 114.00K | -USD 36.43M | USD 494.00K | -2500.0% | -0.3 | USD 309.00K | USD 13.73M | USD 2.60M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 252.42M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Regent Pacific Group Limited
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Regent Pacific Group Limited's market cap?
Regent Pacific Group Limited's market capitalization is HKD 252.42M.
What does Regent Pacific Group Limited do?
Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels.